Epilepsy




Epilepsy


The epilepsies are a group of disorders characterized by abnormal electrical activity in the brain. This leads to recurrent unprovoked seizures (Greek: epilēpsia, to seize) in which there are paroxysmal disturbances of movement, sensation or behaviour. The clinical features of a seizure (or ‘ictus’) reflect the location of the abnormal discharges and their extent of spread through the cerebral cortex.


Epilepsy is the most common serious neurological disorder worldwide, affecting up to 1% of the general population. A single seizure does not usually warrant a diagnosis of epilepsy; in most cases, this requires two or more unprovoked seizures separated by at least 24 hours. Provoked seizures are distinct from epilepsy and occur in up to 5% of people at some point in their lifetime; causes include head injury, stroke, infection, fever, alcohol withdrawal and metabolic derangements.



Types of seizure


The two main types of seizure are illustrated in Fig. 11.1. Primary generalized seizures diffusely involve both cerebral hemispheres at onset and consciousness is usually lost. Partial (focal) seizures have a discrete cortical origin and the clinical features reflect the function of the affected area. Abnormal electrical activity can often be recorded during a seizure using scalp electrodes (discussed below).





Partial (focal) seizures


This type of seizure arises from a discrete focus such as a cortical malformation or tumour. In simple partial seizures there is a disturbance of motor, sensory, cognitive or autonomic function without loss of consciousness. In complex partial seizures, the focal symptoms are accompanied by disturbance of normal awareness or responsiveness. Complex partial seizures commonly originate in the temporal lobe. They are frequently preceded by an aura (Latin: breeze or soft wind) such as a strange sensation or an unpleasant smell.


A secondarily generalized seizure occurs when a partial seizure spreads to involve both cerebral hemispheres. This may be preceded by focal symptoms (e.g. involuntary limb movement or head turning), but these can be missed if generalization is rapid. The presence of localizing neurological signs after the seizure (such as weakness) provides an important clue that there is a discrete (focal) cortical origin.




General aspects


There are numerous epilepsy syndromes with differences in seizure type, age at onset, presumed aetiology and EEG findings (Clinical Box 11.1). They can be classified in different ways such as mode of onset (generalized versus focal) or age at presentation. Many epilepsy syndromes arise in childhood and some have highly characteristic features (Clinical Boxes 11.2, 11.3 & 11.4).



image Clinical Box 11.1:   Electroencephalography (EEG)


Electrical recording from the scalp can be used to look for epileptiform discharges from the cerebral cortex to support a clinical diagnosis of epilepsy (Figs 11.2 & 11.3). An abnormal interictal trace is recorded in around 50% of people with clinically definite epilepsy, but the diagnostic yield can be increased to 80% by sleep deprivation, hyperventilation or intermittent photic stimulation (flickering light). In some cases it is not possible to record epileptiform discharges, even during a seizure (for instance, if the seizure focus is too deeply seated to be picked up by scalp electrodes). The false positive rate is 0.5% in adults and 4% in children.









Common seizure patterns


Despite the large number of epilepsy syndromes, there are several commonly encountered types of seizure, each with distinctive semiology (clinical manifestations). An example of a simple partial seizure has been described in Clinical Box 11.2; in the following sections, typical features of a complex partial seizure and two very different forms of primary generalized seizure will be described.



Complex partial seizures


The most common partial epilepsy syndrome is temporal lobe epilepsy (TLE) which is characterized by simple and complex partial seizures of temporal lobe origin, often with secondary generalization. A typical complex partial seizure in temporal lobe epilepsy lasts less than two minutes and may begin with an aura. This may be a peculiar smell, reflecting the role of the mesial temporal lobe in olfaction, or a strange ‘rising’ sensation between the epigastrium and throat. As the seizure takes hold the patient stops what they are doing and enters a state of altered consciousness. They may feel a strong sense of familiarity (déjà vu) or a strange feeling of unfamiliarity (jamais vu). The experiences sometimes have religious or spiritual connotations and may be associated with euphoria. At this point it becomes impossible to converse with the patient and there may be repetitive, semi-purposeful actions such as chewing, lip-smacking, picking at clothing or aimless reaching. These behaviours are referred to as automatisms (automatic behaviours). The seizure is followed by a period of postictal confusion with little recollection of the episode.



Generalized tonic-clonic seizures


This is the convulsive type of seizure (formerly known as grand mal) that most people associate with the word epilepsy and is the most common form of seizure overall. There may be a prodromal phase, 24–48 hours before the attack. This is characterized by light-headedness, malaise or a sense that something is about to happen. The seizure may begin with an aura, followed by distinct tonic (rigid) and clonic (jerking) phases.



Tonic phase (30 seconds)

Intense neuronal discharges from the cerebral cortex cause the entire body to become rigid (Fig. 11.4A). Spasm of the laryngeal and respiratory muscles forces air out of the chest, often producing an epileptic cry. The eyes deviate upwards and the patient falls stiffly to the ground, remaining in a state of tonic muscular contraction. Breathing ceases temporarily, leading to cyanosis.




Clonic phase (60 seconds)

This is characterized by violent, symmetrical convulsions, with muscular contraction and relaxation (Fig. 11.4B). Breathing is noisy and poorly coordinated, with salivation that appears as ‘frothing at the mouth’. The face may be pink and congested or cyanosis may persist if ventilation is poor. Tongue biting and other injuries sometimes occur and the patient may be incontinent of urine. As the clonic phase comes to an end the jerking movements gradually subside.




Absence seizures


This is another type of primary generalized seizure (formerly known as petit mal) that commonly occurs in childhood absence epilepsy. Absences are characterized by brief (5–10-second) episodes in which the patient becomes unaware of their surroundings. These occur unpredictably, with abrupt onset and offset. During an absence the patient stops whatever he or she is doing and becomes unresponsive, but maintains normal posture and muscle tone. The expression is blank, sometimes with fine flickering of the eyelids or face. There is no aura or postictal confusion and patients are often unaware that anything has happened. Frequent absences may cause severe disruption to concentration and impaired school performance.




Genetic factors in epilepsy


The risk of epilepsy is 2–3 times greater in those with an affected parent, sibling or child and the concordance rates are significantly higher in identical twins. In most cases the heritable component is complex and polygenetic, involving multiple genes interacting with environmental variables, but single-gene disorders are also described.



Inherited seizure disorders


Approximately 2% of epilepsy syndromes show a clear pattern of Mendelian inheritance. This is most often autosomal dominant with variable penetrance, but examples of autosomal recessive, X-linked and mitochondrial inheritance have also been described. Most known mutations affect ion channels (sodium, potassium, calcium or chloride) and these disorders are referred to as channelopathies. This is assumed to alter the balance of excitatory and inhibitory influences and may be associated with focal or generalized seizures.


There are very few single-gene conditions in which epilepsy is the main feature. An example is the syndrome of benign familial neonatal seizures, an autosomal dominant voltage-gated potassium channelopathy which tends to spontaneously remit in adulthood. Another is autosomal dominant nocturnal frontal lobe epilepsy, caused by mutations in the nicotinic acetylcholine receptor gene. A separate group of conditions cause a progressive myoclonic epilepsy syndrome, with shock-like myoclonic jerks and gradual intellectual decline.




Diagnosis and management


The diagnosis of epilepsy is clinical and requires a detailed eyewitness account of the episodes. If EEG is performed, this may provide evidence to support the clinical diagnosis. Video recording combined with EEG (referred to as telemetry) may be particularly helpful in difficult cases (Fig. 11.5). Epilepsy can usually be managed pharmacologically, but a neurosurgical procedure may be suitable in a minority of cases. In some patients, the less invasive option of a vagus nerve stimulator may be considered (Clinical Box 11.5).





Anti-epileptic drugs (AEDs)


Two thirds of patients can be managed effectively with anti-epileptic drugs and adequate control is usually achieved with a single agent (monotherapy). Some of the important side effects of anti-epileptic drugs are discussed in Clinical Box 11.6.



image Clinical Box 11.6:   AED side effects


Some common and important side effects of anti-epileptic drugs are illustrated in Fig. 11.6. Most are central nervous system depressants, so they tend to cause drowsiness and impaired concentration. Many have a toxic effect on the cerebellum, especially when serum levels are high, causing dysarthria (slurred speech), diplopia (double vision) and ataxia (incoordination). Other agents have specific side effects including allergic reactions, skin rashes, gum hypertrophy, acne or hirsuitism. As a group, anti-epileptic agents are known to be teratogenic (Greek: teras, monster) increasing the risk of birth defects from 2% to 6%. Sodium valproate carries the greatest risk, but teratogenicity is also increased in patients receiving more than one anti-epileptic agent (polytherapy).




Mechanisms of action


A minority of anti-epileptic agents are the product of rational drug design, based upon knowledge of cellular events in epileptogenesis. Most are discovered fortuitously or by systematic screening of a large number of candidate compounds in an animal model of epilepsy. For this reason the mode of action is not always clear, but most agents fall into one of four main categories (discussed below).





GABA potentiators

These drugs increase activity at inhibitory synapses (see Ch. 7). Some act via post-synaptic GABAA receptors which are linked to a chloride ion channel; this stabilizes the neuronal membrane via an inward chloride (Cl) current. These include (i) benzodiazepines (e.g. clonazepam, diazepam) which increase the frequency of channel opening and (ii) barbiturates (e.g. primidone, phenobarbital) which increase the duration of channel opening. Others act at metabotropic (G-protein-coupled) GABAB receptors which influence second messenger cascades; this causes longer-lasting hyperpolarization of the neuronal membrane by opening potassium channels. Several anti-epileptic agents increase the amount of GABA available by modulating its synthesis (sodium valproate), reuptake (tiagabine), release (gabapentin) or breakdown (vigabatrin).

< div class='tao-gold-member'>

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Jun 19, 2016 | Posted by in NEUROLOGY | Comments Off on Epilepsy

Full access? Get Clinical Tree

Get Clinical Tree app for offline access